搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按相关度排序
按时间排序
Managed Healthcare Executive
2 天
The Good and Bad About Melanoma
Five-year survival rates improved greatly because of immunotherapy and other advances, according to the American Cancer ...
Managed Healthcare Executive
2 天
The Good and Bad News About Melanoma
Five-year survival rates improved greatly because of immunotherapy and other advances, according to the American Cancer ...
Medpage Today on MSN
6 天
Childhood Cancer Survivors Have Double the Risk of Melanoma as Adults
Childhood cancer survivors had greater than twofold increased risk of invasive skin and ocular melanoma (95% CI 1.6-2.4) ...
HealthDay on MSN
4 天
Diabetes Drug Protects Against Skin Cancer, New Research Says
A popular diabetes drug can provide protection against skin cancers, a new study says.Metformin significantly reduces ...
The Hoya
5 天
GU Hospital Rolls Out Breakthrough Melanoma Treatment
The MedStar Georgetown University Hospital began implementing a new treatment for metastatic melanoma that fights a patient’s ...
4 天
on MSN
A tiny anticancer weapon: Nano-sized particles trigger tumor cell self-destruction
A new twist on a decades-old anticancer strategy has shown powerful effects against multiple cancer types in a preclinical ...
The American Journal of Managed Care
4 天
Diabetes Drug Metformin May Have Another Use: Protecting Against Skin Cancer
Metformin, a widely prescribed medication for type 2 diabetes, may help protect individuals from the 2 most common types of ...
5 天
Diabetes drug metformin linked to reduced skin cancer risk
A popular diabetes drug may provide protection against skin cancers, a new study says. Metformin significantly reduces people ...
News Medical on MSN
3 天
Cancer researchers shed light on how immune cell clusters form
A research team at Memorial Sloan Kettering Cancer Center (MSK) has made new insights into how the body forms immune cell ...
GlobalData on MSN
3 天
Evaxion concludes subject dosing in Phase II trial of melanoma vaccine
Evaxion Biotech has completed subject dosing in the Phase II trial of EVX-01, for the treatment of advanced melanoma.
manilastandard
11 小时
FUDA Cancer Hospital shows no borders in cancer treatment
Cancer is one of the world’s leading causes of death. It is the third leading cause of death in the Philippines in 2023, ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈